Integrin Receptor Antagonist [EPC]

Integrin Receptor Antagonist [EPC] was reported 87058 times

Drugs of the Integrin Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 THERAPEUTIC REACTION TIME DECREASED 2756 0.9438
1 VAGINAL FLATULENCE 190 0.6271
2 DRUG DELIVERY DEVICE IMPLANTATION 121 0.5500
3 JC VIRUS TEST POSITIVE 382 0.4537
4 COLITIS ULCERATIVE 15796 0.3530
5 LOSS OF THERAPEUTIC RESPONSE 1082 0.3391
6 AGRAPHIA 198 0.3317
7 GENERAL SYMPTOM 2418 0.3223
8 NEUTRALISING ANTIBODIES POSITIVE 131 0.3141
9 ILEOCAECAL RESECTION 107 0.3110
10 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 174 0.3102
11 POOR VENOUS ACCESS 3165 0.3056
12 INFUSION SITE HAEMATOMA 145 0.3046
13 NEUROMYELITIS OPTICA 97 0.2904
14 STEROID DEPENDENCE 251 0.2859
15 LOSS OF CONTROL OF LEGS 1067 0.2813
16 OPPORTUNISTIC INFECTION 508 0.2744
17 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 504 0.2679
18 MUCOUS STOOLS 1326 0.2674
19 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2174 0.2634
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 166 0.2485
21 MULTIPLE SCLEROSIS RELAPSE 16980 0.2475
22 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 790 0.2381
23 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1186 0.2378
24 DEFAECATION URGENCY 1558 0.2221
25 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 442 0.2131
26 MULTIPLE SCLEROSIS 9959 0.2081
27 PROGRESSIVE MULTIPLE SCLEROSIS 235 0.2035
28 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 97 0.2004
29 DISLOCATION OF VERTEBRA 451 0.1975
30 FREQUENT BOWEL MOVEMENTS 5332 0.1972
31 DRUG SPECIFIC ANTIBODY PRESENT 1278 0.1963
32 GASTROINTESTINAL STOMA OUTPUT INCREASED 87 0.1855
33 FAECAL CALPROTECTIN INCREASED 585 0.1845
34 POUCHITIS 158 0.1835
35 CATARRH 165 0.1825
36 FEMALE GENITAL TRACT FISTULA 299 0.1750
37 BAND SENSATION 220 0.1734
38 X-RAY ABNORMAL 304 0.1698
39 RECTAL TENESMUS 201 0.1613
40 TERMINAL ILEITIS 97 0.1580
41 LARGE INTESTINAL STENOSIS 301 0.1504
42 PROCTITIS 418 0.1491
43 ILEAL STENOSIS 257 0.1445
44 LUPUS VULGARIS 180 0.1429
45 INTESTINAL ANASTOMOSIS 92 0.1429
46 GASTROINTESTINAL SCARRING 100 0.1379
47 PERONEAL NERVE PALSY 775 0.1363
48 SENSATION OF HEAVINESS 527 0.1357
49 PRESCRIBED UNDERDOSE 2703 0.1354
50 RELAPSING-REMITTING MULTIPLE SCLEROSIS 114 0.1319
51 HEMIANAESTHESIA 105 0.1316
52 CHOLANGITIS SCLEROSING 263 0.1279
53 FAECES SOFT 930 0.1277
54 ANTIBODY TEST POSITIVE 212 0.1276
55 VEIN DISORDER 634 0.1266
56 CENTRAL NERVOUS SYSTEM LESION 1698 0.1235
57 DEEP VEIN THROMBOSIS POSTOPERATIVE 247 0.1233
58 INFUSION SITE BRUISING 264 0.1221
59 INTESTINAL STENOSIS 503 0.1191
60 ILEAL ULCER 120 0.1186
61 RETINITIS 205 0.1186
62 BURNS SECOND DEGREE 206 0.1173
63 ANAL ABSCESS 626 0.1160
64 SERONEGATIVE ARTHRITIS 132 0.1152
65 ILEOSTOMY 291 0.1139
66 COLECTOMY 643 0.1137
67 HAEMATOCHEZIA 6262 0.1133
68 FRUSTRATION 401 0.1118
69 MUSCLE SPASTICITY 1346 0.1094
70 RECTAL ABSCESS 181 0.1078
71 SWOLLEN JOINT COUNT INCREASED 338 0.1059
72 ANAL FISTULA 557 0.1043
73 NEUROGENIC BLADDER 214 0.1013
74 INTESTINAL FISTULA 141 0.1001
75 JC POLYOMAVIRUS TEST POSITIVE 117 0.0999
76 DRUG LEVEL DECREASED 1017 0.0998
77 SMALL INTESTINAL STENOSIS 105 0.0986
78 TRIGEMINAL NEURALGIA 395 0.0981
79 PREGNANCY 1941 0.0968
80 STRESS AT WORK 108 0.0957
81 PORPHYRIA ACUTE 137 0.0955
82 ABSCESS INTESTINAL 202 0.0937
83 MUSCULOSKELETAL DISORDER 1778 0.0933
84 DYSCHEZIA 284 0.0929
85 RHEUMATIC FEVER 414 0.0928
86 OPTIC NEURITIS 824 0.0906
87 GASTROINTESTINAL VIRAL INFECTION 94 0.0903
88 COORDINATION ABNORMAL 1237 0.0886
89 ANAL FISSURE 470 0.0875
90 RADICULOPATHY 230 0.0872
91 DYSGRAPHIA 558 0.0846
92 GASTROINTESTINAL WALL THICKENING 124 0.0828
93 CENTRAL VENOUS CATHETERISATION 248 0.0821
94 GASTROINTESTINAL INFLAMMATION 643 0.0820
95 SMALL INTESTINAL RESECTION 92 0.0789
96 GASTROINTESTINAL BACTERIAL INFECTION 90 0.0787
97 TEMPERATURE INTOLERANCE 813 0.0787
98 INTRADUCTAL PROLIFERATIVE BREAST LESION 98 0.0783
99 COGNITIVE DISORDER 3626 0.0776
100 ABDOMINAL MASS 206 0.0768
101 RHEUMATOID FACTOR POSITIVE 442 0.0764
102 INVASIVE DUCTAL BREAST CARCINOMA 199 0.0731
103 LARGE INTESTINAL ULCER 198 0.0729
104 VEIN RUPTURE 120 0.0716
105 CLOSTRIDIUM DIFFICILE INFECTION 1558 0.0713
106 ANAL INCONTINENCE 641 0.0712
107 BALANCE DISORDER 5948 0.0687
108 DECREASED IMMUNE RESPONSIVENESS 664 0.0676
109 LARGE INTESTINE POLYP 467 0.0673
110 FACET JOINT SYNDROME 217 0.0666
111 CLUMSINESS 178 0.0652
112 FISTULA 727 0.0646
113 ABASIA 1591 0.0643
114 DECUBITUS ULCER 517 0.0634
115 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 454 0.0633
116 MEMORY IMPAIRMENT 8695 0.0632
117 INTESTINAL ULCER 100 0.0629
118 PROCTALGIA 403 0.0626
119 COLOSTOMY 123 0.0626
120 HYPOAESTHESIA FACIAL 94 0.0625
121 WOUND INFECTION 685 0.0625
122 HELICOBACTER INFECTION 640 0.0622
123 INFUSION SITE EXTRAVASATION 385 0.0618
124 CYTOMEGALOVIRUS COLITIS 142 0.0617
125 GASTROINTESTINAL STOMA COMPLICATION 97 0.0617
126 MOBILITY DECREASED 4429 0.0616
127 VAGINAL INFECTION 290 0.0616
128 DISCOURAGEMENT 144 0.0615
129 RECTAL HAEMORRHAGE 2627 0.0611
130 MULTIPLE ALLERGIES 478 0.0609
131 MATERNAL EXPOSURE DURING BREAST FEEDING 247 0.0608
132 SPONDYLITIS 219 0.0602
133 MUSCLE INJURY 499 0.0602
134 SOCIAL PROBLEM 249 0.0601
135 OPHTHALMIC HERPES ZOSTER 108 0.0598
136 BONE EROSION 211 0.0596
137 DUODENAL ULCER PERFORATION 436 0.0586
138 CHRONIC SINUSITIS 219 0.0583
139 ABDOMINAL ADHESIONS 183 0.0579
140 BLADDER DISORDER 568 0.0571
141 ANAL HAEMORRHAGE 158 0.0564
142 DIARRHOEA HAEMORRHAGIC 526 0.0562
143 ADENOCARCINOMA OF COLON 105 0.0560
144 PUSTULAR PSORIASIS 191 0.0556
145 LATENT TUBERCULOSIS 116 0.0553
146 SERUM FERRITIN DECREASED 95 0.0549
147 FOLLICULITIS 573 0.0546
148 MOTOR DYSFUNCTION 550 0.0539
149 INTESTINAL RESECTION 288 0.0535
150 GAIT DISTURBANCE 10220 0.0533
151 ABDOMINAL ABSCESS 235 0.0531
152 HYPOPNOEA 183 0.0527
153 STENOSIS 99 0.0527
154 CYSTITIS 1651 0.0518
155 HEMIPARESIS 876 0.0517
156 FAECAL INCONTINENCE 248 0.0516
157 CERVICAL DYSPLASIA 112 0.0513
158 INFECTION SUSCEPTIBILITY INCREASED 112 0.0511
159 APPENDICITIS PERFORATED 130 0.0511
160 ALCOHOL POISONING 137 0.0511
161 WALKING AID USER 337 0.0511
162 GASTROINTESTINAL INFECTION 454 0.0506
163 FRUSTRATION TOLERANCE DECREASED 397 0.0491
164 APPENDICECTOMY 175 0.0490
165 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 317 0.0488
166 FAECES HARD 189 0.0485
167 PYODERMA GANGRENOSUM 174 0.0483
168 INFECTED SKIN ULCER 90 0.0476
169 MENTAL IMPAIRMENT 1154 0.0476
170 ERYTHEMA NODOSUM 165 0.0470
171 RECTAL DISCHARGE 173 0.0469
172 PERIPHERAL VENOUS DISEASE 191 0.0467
173 CAESAREAN SECTION 544 0.0467
174 C-REACTIVE PROTEIN ABNORMAL 297 0.0463
175 GRIP STRENGTH DECREASED 405 0.0460
176 HAND DEFORMITY 601 0.0458
177 MUSCULAR WEAKNESS 5195 0.0457
178 BRONCHIECTASIS 307 0.0455
179 PHARYNGITIS STREPTOCOCCAL 493 0.0455
180 INFECTIOUS MONONUCLEOSIS 102 0.0455
181 HYPERCHOLESTEROLAEMIA 438 0.0453
182 DYSPHEMIA 198 0.0451
183 URINARY TRACT INFECTION 7540 0.0442
184 IRON DEFICIENCY 197 0.0438
185 ESCHERICHIA URINARY TRACT INFECTION 186 0.0437
186 VITAMIN B12 DECREASED 126 0.0437
187 JOINT RANGE OF MOTION DECREASED 582 0.0434
188 HYPOAESTHESIA 6440 0.0430
189 RASH VESICULAR 207 0.0428
190 INTESTINAL OBSTRUCTION 1603 0.0425
191 UROSEPSIS 392 0.0424
192 HEARING IMPAIRED 253 0.0421
193 ABORTION SPONTANEOUS 1679 0.0419
194 BLOOD IRON DECREASED 494 0.0416
195 APPENDICITIS 388 0.0415
196 JOINT DISLOCATION 439 0.0415
197 ABNORMAL FAECES 340 0.0415
198 HAEMORRHOIDS 807 0.0413
199 APHASIA 1248 0.0413
200 LOWER LIMB FRACTURE 790 0.0411
201 PEMPHIGUS 514 0.0411
202 COLITIS 1543 0.0407
203 COLITIS MICROSCOPIC 192 0.0405
204 IRRITABLE BOWEL SYNDROME 865 0.0403
205 POST PROCEDURAL INFECTION 328 0.0403
206 ABDOMINAL HERNIA 179 0.0392
207 DRUG EFFECT LESS THAN EXPECTED 579 0.0390
208 VITAMIN D DECREASED 334 0.0390
209 INFLAMMATORY BOWEL DISEASE 381 0.0389
210 LUPUS-LIKE SYNDROME 353 0.0389
211 INCONTINENCE 411 0.0388
212 INCORRECT DRUG ADMINISTRATION RATE 165 0.0387
213 SMALL INTESTINAL OBSTRUCTION 476 0.0386
214 READING DISORDER 88 0.0385
215 PERICARDITIS 645 0.0384
216 EXCORIATION 97 0.0382
217 NASOPHARYNGITIS 7035 0.0381
218 BREAST CANCER STAGE III 247 0.0381
219 INFUSION SITE PAIN 489 0.0379
220 FOOD POISONING 203 0.0379
221 CLOSTRIDIAL INFECTION 128 0.0378
222 UPPER RESPIRATORY TRACT CONGESTION 109 0.0376
223 GASTROENTERITIS VIRAL 679 0.0376
224 LYMPHOCYTE COUNT INCREASED 121 0.0370
225 CONCUSSION 286 0.0369
226 FIBROMYALGIA 895 0.0368
227 INTERVERTEBRAL DISC PROTRUSION 803 0.0367
228 SENSORY DISTURBANCE 588 0.0366
229 ANIMAL BITE 97 0.0364
230 ABSCESS 579 0.0363
231 ANKLE FRACTURE 561 0.0362
232 IMPAIRED QUALITY OF LIFE 521 0.0362
233 ENDOMETRIOSIS 172 0.0360
234 POSTOPERATIVE WOUND INFECTION 241 0.0356
235 LOWER RESPIRATORY TRACT INFECTION 1609 0.0353
236 HERPES ZOSTER 2025 0.0352
237 FIBULA FRACTURE 101 0.0350
238 BACK DISORDER 569 0.0350
239 ABDOMINAL PAIN 8138 0.0349
240 LIGAMENT RUPTURE 154 0.0348
241 ABSCESS LIMB 148 0.0347
242 INFUSION SITE REACTION 103 0.0344
243 KIDNEY INFECTION 676 0.0344
244 SLUGGISHNESS 351 0.0344
245 EXOSTOSIS 313 0.0342
246 EAR INFECTION 912 0.0342
247 RHINITIS 276 0.0342
248 SINUSITIS 3494 0.0341
249 APHAGIA 162 0.0336
250 PRODUCT AVAILABILITY ISSUE 764 0.0335
251 AUTOIMMUNE DISORDER 327 0.0335
252 UTERINE LEIOMYOMA 245 0.0335
253 FATIGUE 26064 0.0334
254 MUSCLE TIGHTNESS 539 0.0332
255 URINARY INCONTINENCE 980 0.0330
256 SPINAL FUSION SURGERY 133 0.0328
257 CATHETER SITE PAIN 85 0.0327
258 ANORECTAL DISCOMFORT 174 0.0327
259 PRODUCT TEMPERATURE EXCURSION ISSUE 168 0.0327
260 GASTROINTESTINAL PAIN 356 0.0323
261 ROAD TRAFFIC ACCIDENT 1351 0.0323
262 AMNESIA 2094 0.0322
263 ENTERITIS 205 0.0320
264 INFLUENZA 3538 0.0317
265 SPEECH DISORDER 1657 0.0316
266 DIPLOPIA 818 0.0315
267 TOOTH INFECTION 415 0.0314
268 NEPHROLITHIASIS 1437 0.0313
269 EXPOSURE VIA BREAST MILK 124 0.0311
270 GAIT INABILITY 1038 0.0310
271 MALIGNANT MELANOMA 411 0.0306
272 ARTHROPOD BITE 227 0.0306
273 WOUND 854 0.0305
274 LIP DRY 275 0.0302
275 HYSTERECTOMY 262 0.0302
276 PARAPLEGIA 87 0.0301
277 BRONCHITIS 2231 0.0301
278 DYSSTASIA 871 0.0298
279 GINGIVAL PAIN 237 0.0297
280 SYNOVITIS 533 0.0295
281 VITAMIN B12 DEFICIENCY 119 0.0294
282 DEMYELINATION 120 0.0293
283 ECTOPIC PREGNANCY 90 0.0292
284 MONOPLEGIA 127 0.0292
285 IRON DEFICIENCY ANAEMIA 268 0.0290
286 INJECTION SITE DISCHARGE 156 0.0290
287 GLOSSODYNIA 647 0.0289
288 PAROSMIA 218 0.0289
289 GASTROENTERITIS 421 0.0288
290 LYME DISEASE 96 0.0288
291 MIGRAINE 2736 0.0286
292 FALL 9493 0.0285
293 HIP ARTHROPLASTY 435 0.0284
294 IMPAIRED HEALING 927 0.0282
295 BURSITIS 342 0.0282
296 VIRAL INFECTION 936 0.0281
297 BREAST CANCER STAGE II 234 0.0281
298 VITAMIN D DEFICIENCY 273 0.0280
299 TONSILLITIS 146 0.0279
300 BLEPHAROSPASM 175 0.0278
301 THERAPY NON-RESPONDER 1245 0.0277
302 INFUSION SITE HAEMORRHAGE 91 0.0276
303 ASTHENIA 10397 0.0276
304 SCIATICA 440 0.0276
305 ABDOMINAL PAIN LOWER 697 0.0275
306 TIBIA FRACTURE 129 0.0275
307 LIGAMENT SPRAIN 271 0.0274
308 VAGINAL DISCHARGE 277 0.0273
309 BASAL CELL CARCINOMA 427 0.0273
310 APHTHOUS ULCER 211 0.0272
311 UPPER RESPIRATORY TRACT INFECTION 1256 0.0272
312 UMBILICAL HERNIA 127 0.0271
313 FOOT FRACTURE 515 0.0271
314 NEURALGIA 660 0.0271
315 INFLUENZA LIKE ILLNESS 2224 0.0270
316 MALAISE 11845 0.0270
317 TOOTH ABSCESS 275 0.0270
318 VIITH NERVE PARALYSIS 93 0.0269
319 MUSCULOSKELETAL STIFFNESS 2359 0.0269
320 INJECTION SITE EXTRAVASATION 331 0.0268
321 INFUSION RELATED REACTION 1777 0.0268
322 MATERNAL EXPOSURE DURING PREGNANCY 2381 0.0267
323 ADVERSE REACTION 354 0.0267
324 OFF LABEL USE 23325 0.0266
325 VISUAL IMPAIRMENT 3289 0.0265
326 MICTURITION URGENCY 302 0.0264
327 DRUG EFFECT DECREASED 1421 0.0264
328 ORAL INFECTION 103 0.0263
329 ORAL CANDIDIASIS 345 0.0262
330 FEELING COLD 729 0.0262
331 BLINDNESS UNILATERAL 369 0.0261
332 WHITE BLOOD CELL COUNT INCREASED 1003 0.0261
333 INFLAMMATORY MARKER INCREASED 129 0.0260
334 URINARY TRACT DISORDER 117 0.0260
335 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4645 0.0257
336 CROHN'S DISEASE 176 0.0257
337 CARDIAC MURMUR 222 0.0256
338 DIVERTICULUM INTESTINAL 112 0.0256
339 PULMONARY FIBROSIS 488 0.0254
340 DRUG LEVEL BELOW THERAPEUTIC 140 0.0254
341 HYPERSOMNIA 726 0.0253
342 PYELONEPHRITIS 217 0.0250
343 SYSTEMIC LUPUS ERYTHEMATOSUS 883 0.0249
344 CEREBRAL ATROPHY 99 0.0248
345 AUTOIMMUNE HAEMOLYTIC ANAEMIA 85 0.0248
346 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 177 0.0247
347 PRE-ECLAMPSIA 117 0.0246
348 BLINDNESS TRANSIENT 181 0.0245
349 CLOSTRIDIUM DIFFICILE COLITIS 258 0.0243
350 CERVIX CARCINOMA 95 0.0243
351 OBSTRUCTION 97 0.0243
352 PRODUCT DISTRIBUTION ISSUE 225 0.0242
353 BACK INJURY 263 0.0242
354 SPINAL COLUMN STENOSIS 114 0.0241
355 BLOOD TEST ABNORMAL 339 0.0241
356 COMMUNICATION DISORDER 92 0.0240
357 INTERVERTEBRAL DISC DISORDER 102 0.0239
358 CHRONIC LYMPHOCYTIC LEUKAEMIA 113 0.0238
359 LACERATION 224 0.0238
360 IMPAIRED WORK ABILITY 506 0.0236
361 KNEE ARTHROPLASTY 494 0.0234
362 FACE INJURY 89 0.0234
363 SUBCUTANEOUS ABSCESS 112 0.0233
364 WEIGHT FLUCTUATION 244 0.0233
365 HERPES VIRUS INFECTION 134 0.0232
366 DISABILITY 459 0.0232
367 MYOSITIS 208 0.0232
368 NEUROLOGICAL SYMPTOM 132 0.0231
369 HAND FRACTURE 163 0.0230
370 FOOT DEFORMITY 255 0.0230
371 PHARYNGITIS 285 0.0230
372 MUSCLE FATIGUE 97 0.0229
373 OVARIAN CYST 228 0.0228
374 HERNIA 440 0.0227
375 DYSARTHRIA 856 0.0227
376 GALLBLADDER OPERATION 92 0.0227
377 WHEELCHAIR USER 101 0.0227
378 INTERVERTEBRAL DISC DEGENERATION 210 0.0227
379 HEADACHE 14191 0.0226
380 MALNUTRITION 253 0.0226
381 ABDOMINAL TENDERNESS 112 0.0225
382 PAIN IN EXTREMITY 6643 0.0225
383 BOWEL MOVEMENT IRREGULARITY 172 0.0224
384 HEAD INJURY 710 0.0224
385 JOINT STIFFNESS 588 0.0224
386 VULVOVAGINAL MYCOTIC INFECTION 88 0.0223
387 BODY TEMPERATURE DECREASED 220 0.0223
388 MUSCLE SPASMS 4062 0.0221
389 DEPRESSED MOOD 1165 0.0220
390 LOW BIRTH WEIGHT BABY 175 0.0220
391 TYPE 2 DIABETES MELLITUS 739 0.0219
392 VERTIGO 1336 0.0219
393 SINUS HEADACHE 130 0.0219
394 PARAESTHESIA 3436 0.0218
395 ENCEPHALITIS 151 0.0218
396 OVERWEIGHT 117 0.0218
397 ORAL HERPES 424 0.0217
398 UVEITIS 293 0.0216
399 SPINAL DISORDER 204 0.0215
400 INFECTION 3116 0.0215
401 FLATULENCE 1220 0.0215
402 SKIN INFECTION 241 0.0215
403 MELANOCYTIC NAEVUS 94 0.0214
404 RED BLOOD CELL SEDIMENTATION RATE INCREASED 237 0.0214
405 COLON CANCER 319 0.0214
406 HYPERSENSITIVITY 3968 0.0214
407 CHOLECYSTECTOMY 244 0.0213
408 TREATMENT FAILURE 1765 0.0213
409 GASTROINTESTINAL MOTILITY DISORDER 114 0.0213
410 ESCHERICHIA INFECTION 175 0.0213
411 SENSORY LOSS 171 0.0212
412 CONFUSIONAL STATE 3427 0.0212
413 GASTROINTESTINAL SOUNDS ABNORMAL 105 0.0212
414 CELLULITIS 1067 0.0212
415 HEPATIC ENZYME INCREASED 1442 0.0211
416 ARTHRITIS INFECTIVE 98 0.0211
417 HEPATIC CIRRHOSIS 397 0.0211
418 ARTHRITIS 1659 0.0211
419 TOOTH FRACTURE 232 0.0210
420 UPPER LIMB FRACTURE 418 0.0210
421 INFUSION SITE SWELLING 132 0.0210
422 THERAPEUTIC PRODUCT EFFECT DECREASED 936 0.0209
423 EYE MOVEMENT DISORDER 143 0.0209
424 EAR PAIN 406 0.0209
425 BODY TEMPERATURE INCREASED 426 0.0209
426 FACIAL PAIN 186 0.0208
427 GESTATIONAL DIABETES 99 0.0208
428 SURGERY 1214 0.0207
429 STAPHYLOCOCCAL INFECTION 683 0.0207
430 CONTUSION 1992 0.0207
431 POST PROCEDURAL COMPLICATION 397 0.0207
432 FURUNCLE 163 0.0205
433 IMMUNE SYSTEM DISORDER 271 0.0205
434 AUTOIMMUNE HEPATITIS 143 0.0205
435 MOUTH ULCERATION 433 0.0205
436 BIPOLAR DISORDER 223 0.0205
437 LIVER INJURY 502 0.0204
438 THERAPY PARTIAL RESPONDER 319 0.0204
439 VISUAL ACUITY REDUCED 678 0.0204
440 INTESTINAL PERFORATION 229 0.0204
441 PERIPHERAL COLDNESS 280 0.0204
442 DEAFNESS UNILATERAL 112 0.0203
443 DIVERTICULITIS 563 0.0203
444 JOINT INJURY 433 0.0202
445 INGUINAL HERNIA 123 0.0202
446 POLYP 132 0.0201
447 WRIST FRACTURE 239 0.0199
448 HEMIPLEGIA 165 0.0198
449 DEVICE RELATED INFECTION 304 0.0197
450 FEAR 528 0.0196
451 SKIN CANCER 422 0.0196
452 BRADYPHRENIA 128 0.0196
453 ACCIDENT 234 0.0196
454 PARALYSIS 280 0.0195
455 CONVULSION 1112 0.0194
456 MACULAR DEGENERATION 232 0.0194
457 OBESITY 309 0.0194
458 ARTHROPATHY 1074 0.0193
459 OROPHARYNGEAL PAIN 1785 0.0193
460 FEELING HOT 1179 0.0192
461 GENERAL PHYSICAL HEALTH DETERIORATION 2209 0.0191
462 BLOOD PRESSURE DIASTOLIC INCREASED 88 0.0190
463 CEREBRAL DISORDER 141 0.0190
464 STREPTOCOCCAL INFECTION 106 0.0190
465 ARTHRALGIA 7879 0.0189
466 LOCAL SWELLING 330 0.0189
467 HIP FRACTURE 606 0.0188
468 TUBULOINTERSTITIAL NEPHRITIS 353 0.0188
469 BLINDNESS 766 0.0188
470 PROCEDURAL PAIN 521 0.0188
471 NERVE COMPRESSION 173 0.0187
472 URINE ODOUR ABNORMAL 110 0.0187
473 POOR QUALITY SLEEP 401 0.0186
474 LIMB INJURY 505 0.0186
475 NIGHT SWEATS 599 0.0186
476 RIB FRACTURE 382 0.0186
477 MENINGITIS 124 0.0185
478 PRESCRIBED OVERDOSE 357 0.0184
479 FEELING OF DESPAIR 86 0.0184
480 HAEMORRHOIDAL HAEMORRHAGE 90 0.0184
481 DEPRESSION 4193 0.0184
482 SINUS DISORDER 363 0.0183
483 LOCALISED INFECTION 443 0.0183
484 GASTROINTESTINAL DISORDER 1640 0.0183
485 PARAESTHESIA ORAL 264 0.0183
486 PANIC REACTION 132 0.0183
487 HYPERAESTHESIA 150 0.0182
488 ABDOMINAL DISTENSION 1905 0.0182
489 MUSCULOSKELETAL PAIN 956 0.0182
490 ATAXIA 216 0.0182
491 THERMAL BURN 129 0.0182
492 BACK PAIN 4201 0.0181
493 MENISCUS INJURY 111 0.0180
494 INCREASED TENDENCY TO BRUISE 166 0.0180
495 BREAST CANCER FEMALE 480 0.0180
496 CYST 222 0.0179
497 NECK PAIN 986 0.0176
498 DERMATITIS CONTACT 201 0.0176
499 EYE INFECTION 199 0.0176
500 COVID-19 3087 0.0176
501 SQUAMOUS CELL CARCINOMA OF SKIN 106 0.0175
502 INCOHERENT 113 0.0174
503 C-REACTIVE PROTEIN INCREASED 635 0.0174
504 SCOLIOSIS 108 0.0174
505 LARGE INTESTINE PERFORATION 121 0.0174
506 TREMOR 2888 0.0174
507 OSTEOMYELITIS 315 0.0174
508 BLOOD ALBUMIN DECREASED 138 0.0174
509 PARTIAL SEIZURES 91 0.0174
510 RESPIRATORY TRACT INFECTION 451 0.0173
511 SKIN LACERATION 188 0.0173
512 PYREXIA 5939 0.0171
513 BLOOD PRESSURE INCREASED 2621 0.0171
514 CHOLELITHIASIS 562 0.0171
515 FAECES DISCOLOURED 371 0.0171
516 TOOTHACHE 309 0.0171
517 DIARRHOEA 11007 0.0170
518 POST-TRAUMATIC STRESS DISORDER 114 0.0170
519 CARPAL TUNNEL SYNDROME 238 0.0170
520 BREAST MASS 114 0.0170
521 LIVER FUNCTION TEST INCREASED 363 0.0169
522 MUSCLE STRAIN 146 0.0169
523 PNEUMONIA 5456 0.0168
524 OSTEOPOROSIS 693 0.0168
525 WEIGHT DECREASED 4698 0.0168
526 NERVE INJURY 187 0.0168
527 NO ADVERSE EVENT 3044 0.0168
528 ANAPHYLACTIC SHOCK 433 0.0168
529 ILLNESS 1723 0.0167
530 PROCEDURAL COMPLICATION 128 0.0167
531 FEAR OF INJECTION 119 0.0167
532 DELIRIUM 577 0.0166
533 BLOOD PRESSURE DECREASED 1102 0.0166
534 NYSTAGMUS 88 0.0166
535 ASTHENOPIA 91 0.0165
536 INFLAMMATION 852 0.0165
537 EPILEPSY 502 0.0164
538 OSTEOARTHRITIS 694 0.0164
539 PRODUCT DOSE OMISSION ISSUE 4792 0.0163
540 DISCOMFORT 990 0.0162
541 IMMUNOSUPPRESSION 143 0.0162
542 NEOPLASM MALIGNANT 1078 0.0161
543 MAJOR DEPRESSION 118 0.0161
544 VISION BLURRED 2209 0.0161
545 PELVIC FRACTURE 125 0.0160
546 ABDOMINAL PAIN UPPER 3296 0.0160
547 HYPOTONIA 159 0.0159
548 RESPIRATORY TRACT CONGESTION 252 0.0158
549 GALLBLADDER DISORDER 282 0.0158
550 EYE INFLAMMATION 150 0.0157
551 FLANK PAIN 147 0.0157
552 MENTAL DISORDER 679 0.0156
553 NERVOUSNESS 815 0.0156
554 DENTAL CARIES 172 0.0155
555 BURNING SENSATION 1084 0.0154
556 SPINAL PAIN 181 0.0154
557 CHILLS 1810 0.0154
558 APHONIA 215 0.0154
559 FEELING ABNORMAL 3685 0.0154
560 FUNGAL INFECTION 512 0.0153
561 FEELING OF BODY TEMPERATURE CHANGE 90 0.0153
562 ABDOMINAL DISCOMFORT 2571 0.0153
563 VISUAL FIELD DEFECT 110 0.0152
564 BLOOD CHOLESTEROL INCREASED 709 0.0152
565 ROTATOR CUFF SYNDROME 195 0.0152
566 URTICARIA 2540 0.0151
567 CATARACT 890 0.0149
568 SEASONAL ALLERGY 210 0.0148
569 EMOTIONAL DISORDER 457 0.0148
570 MUSCLE DISORDER 120 0.0148
571 RASH PAPULAR 332 0.0148
572 WHITE BLOOD CELL COUNT ABNORMAL 94 0.0147
573 ULCER 234 0.0147
574 HYPOAESTHESIA ORAL 221 0.0146
575 KNEE OPERATION 143 0.0145
576 CONSTIPATION 3170 0.0145
577 URINARY RETENTION 478 0.0143
578 HYPOPHAGIA 365 0.0143
579 PAIN 8734 0.0142
580 MUSCULOSKELETAL CHEST PAIN 220 0.0142
581 SINUS CONGESTION 190 0.0140
582 ANXIETY 3993 0.0140
583 LIMB DISCOMFORT 434 0.0140
584 LYMPHOMA 216 0.0140
585 DEHYDRATION 1860 0.0139
586 HEART RATE DECREASED 489 0.0139
587 MUSCLE TWITCHING 321 0.0139
588 SKIN LESION 381 0.0139
589 THYROID DISORDER 214 0.0139
590 DYSURIA 508 0.0138
591 MUSCLE ATROPHY 174 0.0137
592 THYROID CANCER 165 0.0137
593 RHINORRHOEA 886 0.0137
594 BLOOD MAGNESIUM DECREASED 118 0.0137
595 FOOD ALLERGY 105 0.0136
596 CYTOMEGALOVIRUS INFECTION 225 0.0135
597 EYE DISORDER 444 0.0135
598 BLOOD POTASSIUM DECREASED 406 0.0135
599 PALLOR 367 0.0135
600 BACTERIAL INFECTION 251 0.0134
601 MENSTRUAL DISORDER 111 0.0134
602 PANCREATITIS 708 0.0134
603 LIVER DISORDER 594 0.0134
604 DYSPEPSIA 1311 0.0133
605 BRAIN NEOPLASM 122 0.0133
606 HEPATIC STEATOSIS 247 0.0132
607 SEPSIS 1474 0.0132
608 SARS-COV-2 TEST POSITIVE 174 0.0132
609 BLISTER 739 0.0131
610 LEUKAEMIA 124 0.0131
611 CHEST PAIN 2432 0.0131
612 ADVERSE DRUG REACTION 1179 0.0131
613 DEMENTIA 366 0.0131
614 OEDEMA 710 0.0131
615 SEIZURE 1511 0.0131
616 DIABETES MELLITUS 992 0.0130
617 HIATUS HERNIA 168 0.0130
618 GASTRIC DISORDER 445 0.0130
619 WHEEZING 766 0.0129
620 DEEP VEIN THROMBOSIS 838 0.0129
621 DRUG INEFFECTIVE 16937 0.0128
622 PNEUMONIA ASPIRATION 321 0.0128
623 NASAL CONGESTION 753 0.0128
624 HEART RATE INCREASED 1267 0.0128
625 LYMPHADENOPATHY 452 0.0128
626 BRAIN INJURY 128 0.0128
627 LIVE BIRTH 106 0.0127
628 FLUSHING 1288 0.0127
629 RESPIRATORY DISORDER 378 0.0126
630 PULMONARY MASS 188 0.0126
631 TOOTH EXTRACTION 157 0.0126
632 DIZZINESS 6289 0.0126
633 ALOPECIA 2464 0.0125
634 RETINAL DETACHMENT 115 0.0125
635 PERSONALITY CHANGE 116 0.0125
636 PANIC ATTACK 452 0.0124
637 RENAL PAIN 131 0.0123
638 DISTURBANCE IN ATTENTION 665 0.0123
639 DRUG INTOLERANCE 1186 0.0123
640 EAR DISCOMFORT 126 0.0123
641 PSORIATIC ARTHROPATHY 496 0.0122
642 RENAL CYST 97 0.0122
643 FACIAL PARALYSIS 104 0.0122
644 SPINAL OSTEOARTHRITIS 107 0.0122
645 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 585 0.0122
646 LIVER FUNCTION TEST ABNORMAL 353 0.0121
647 SPINAL FRACTURE 242 0.0121
648 BRAIN FOG 189 0.0120
649 OEDEMA PERIPHERAL 1467 0.0120
650 BLOOD URINE PRESENT 228 0.0120
651 ANGER 405 0.0120
652 WEIGHT INCREASED 2679 0.0120
653 DEAFNESS 312 0.0119
654 DRUG-INDUCED LIVER INJURY 373 0.0119
655 QUALITY OF LIFE DECREASED 159 0.0118
656 IMMUNODEFICIENCY 176 0.0118
657 SECRETION DISCHARGE 147 0.0117
658 ILL-DEFINED DISORDER 713 0.0117
659 RESPIRATORY RATE INCREASED 104 0.0117
660 JOINT SWELLING 1410 0.0117
661 CRYING 423 0.0116
662 SLEEP APNOEA SYNDROME 222 0.0116
663 POLLAKIURIA 485 0.0116
664 MASS 162 0.0116
665 EYE PAIN 652 0.0115
666 PULMONARY EMBOLISM 1088 0.0114
667 LUNG DISORDER 561 0.0114
668 STOMATITIS 694 0.0114
669 IMPAIRED DRIVING ABILITY 130 0.0114
670 ASPIRATION 125 0.0114
671 RASH PRURITIC 618 0.0114
672 OVARIAN CANCER 105 0.0114
673 GRAND MAL CONVULSION 105 0.0114
674 LETHARGY 652 0.0113
675 MOOD SWINGS 361 0.0113
676 PULMONARY THROMBOSIS 123 0.0113
677 LUNG INFECTION 175 0.0113
678 CHOLECYSTITIS 134 0.0112
679 PRURITUS GENERALISED 243 0.0112
680 CORONARY ARTERY OCCLUSION 154 0.0112
681 INJURY 786 0.0112
682 UPPER-AIRWAY COUGH SYNDROME 92 0.0112
683 TOOTH DISORDER 248 0.0111
684 AFFECT LABILITY 107 0.0111
685 PNEUMONIA BACTERIAL 102 0.0111
686 TINNITUS 510 0.0111
687 SLEEP DISORDER 782 0.0111
688 ILEUS 137 0.0110
689 RESTLESS LEGS SYNDROME 199 0.0109
690 HEAD DISCOMFORT 192 0.0108
691 APATHY 158 0.0108
692 NAUSEA 8570 0.0108
693 VASCULITIS 126 0.0108
694 COUGH 3029 0.0108
695 CHEST DISCOMFORT 1100 0.0107
696 PERIPHERAL SWELLING 1654 0.0107
697 EOSINOPHIL COUNT INCREASED 89 0.0107
698 INFUSION SITE ERYTHEMA 90 0.0107
699 INSOMNIA 2841 0.0107
700 THROMBOSIS 855 0.0106
701 DECREASED APPETITE 2458 0.0106
702 VOMITING 4969 0.0106
703 LEUKOCYTOSIS 191 0.0105
704 SWOLLEN TONGUE 329 0.0105
705 DYSPHONIA 607 0.0104
706 STATUS EPILEPTICUS 117 0.0103
707 BREAST CANCER STAGE I 96 0.0103
708 PRODUCTIVE COUGH 492 0.0103
709 HYPOACUSIS 443 0.0103
710 IMPAIRED GASTRIC EMPTYING 140 0.0103
711 GASTRITIS 270 0.0103
712 MYALGIA 1744 0.0102
713 SNEEZING 230 0.0102
714 THROAT TIGHTNESS 276 0.0102
715 MUSCULOSKELETAL DISCOMFORT 174 0.0101
716 POST PROCEDURAL HAEMORRHAGE 117 0.0100
717 SCAR 172 0.0100
718 HAEMOLYTIC ANAEMIA 90 0.0100
719 HYPERTENSION 2113 0.0100
720 BLOOD PRESSURE FLUCTUATION 239 0.0099
721 ANAEMIA 1896 0.0099
722 TENDONITIS 153 0.0099
723 LOSS OF CONSCIOUSNESS 1256 0.0098
724 PRODUCT ADMINISTRATION ERROR 198 0.0098
725 SOMNOLENCE 1964 0.0097
726 COVID-19 PNEUMONIA 115 0.0097
727 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 691 0.0097
728 BLOOD PRESSURE ABNORMAL 193 0.0097
729 COELIAC DISEASE 95 0.0097
730 VITREOUS FLOATERS 95 0.0097
731 SPINAL OPERATION 119 0.0097
732 SWELLING 902 0.0096
733 DERMATITIS ALLERGIC 121 0.0096
734 ADVERSE EVENT 883 0.0096
735 ANAPHYLACTIC REACTION 529 0.0096
736 HOSPITALISATION 1468 0.0095
737 GASTROOESOPHAGEAL REFLUX DISEASE 767 0.0095
738 PLATELET COUNT INCREASED 124 0.0095
739 BLOOD COUNT ABNORMAL 144 0.0095
740 GENERALISED TONIC-CLONIC SEIZURE 157 0.0095
741 ANKYLOSING SPONDYLITIS 125 0.0095
742 REBOUND EFFECT 107 0.0095
743 NEOPLASM 108 0.0094
744 GASTROINTESTINAL CARCINOMA 85 0.0094
745 NERVOUS SYSTEM DISORDER 291 0.0093
746 THROAT IRRITATION 418 0.0093
747 PHOTOPHOBIA 175 0.0093
748 IRRITABILITY 559 0.0093
749 RASH MACULAR 324 0.0093
750 FLUID RETENTION 471 0.0093
751 SQUAMOUS CELL CARCINOMA 87 0.0092
752 OESOPHAGITIS 100 0.0091
753 FEEDING DISORDER 183 0.0090
754 BACTERAEMIA 107 0.0090
755 THINKING ABNORMAL 167 0.0090
756 HAEMOGLOBIN DECREASED 907 0.0088
757 PHOTOSENSITIVITY REACTION 144 0.0087
758 PRURITUS 3345 0.0087
759 RASH 3782 0.0087
760 DYSPHAGIA 823 0.0087
761 SYNCOPE 866 0.0086
762 FOETAL EXPOSURE DURING PREGNANCY 702 0.0086
763 SPLENOMEGALY 101 0.0086
764 LUNG NEOPLASM MALIGNANT 353 0.0086
765 DRY THROAT 87 0.0086
766 SKIN ULCER 221 0.0085
767 CHROMATURIA 192 0.0085
768 ECZEMA 445 0.0085
769 THERAPEUTIC RESPONSE SHORTENED 282 0.0085
770 CONDITION AGGRAVATED 2584 0.0085
771 CONJUNCTIVITIS 157 0.0085
772 COLD SWEAT 149 0.0084
773 HYPERTHYROIDISM 122 0.0084
774 HOT FLUSH 633 0.0084
775 DRUG DOSE OMISSION 1375 0.0083
776 GOUT 149 0.0083
777 BREAST CANCER 771 0.0083
778 CHOKING 161 0.0082
779 TREATMENT NONCOMPLIANCE 451 0.0082
780 LABORATORY TEST ABNORMAL 243 0.0082
781 TENDON RUPTURE 100 0.0081
782 HAEMATOCRIT DECREASED 160 0.0081
783 PNEUMOTHORAX 127 0.0080
784 GASTRIC ULCER 152 0.0080
785 HAEMORRHAGE 836 0.0080
786 DISORIENTATION 316 0.0080
787 ASTHMA 900 0.0080
788 CONTRAINDICATED PRODUCT ADMINISTERED 241 0.0080
789 HEART RATE IRREGULAR 179 0.0079
790 LYMPHOPENIA 112 0.0079
791 EOSINOPHILIA 138 0.0079
792 PALPITATIONS 918 0.0078
793 TRANSIENT ISCHAEMIC ATTACK 264 0.0078
794 INTENTIONAL PRODUCT USE ISSUE 684 0.0078
795 OCULAR DISCOMFORT 87 0.0077
796 MENTAL STATUS CHANGES 215 0.0077
797 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 547 0.0077
798 GLAUCOMA 148 0.0077
799 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
800 MYOCARDITIS 88 0.0077
801 EATING DISORDER 163 0.0076
802 BLOOD CALCIUM DECREASED 86 0.0076
803 CEREBROVASCULAR ACCIDENT 1294 0.0076
804 PANCREATITIS ACUTE 171 0.0076
805 BONE PAIN 445 0.0076
806 SKIN DISORDER 252 0.0075
807 LYMPHOCYTE COUNT DECREASED 132 0.0075
808 SKIN REACTION 105 0.0074
809 ELECTROLYTE IMBALANCE 86 0.0074
810 RHEUMATOID ARTHRITIS 838 0.0074
811 ADRENAL INSUFFICIENCY 89 0.0073
812 SWELLING FACE 476 0.0073
813 THERAPY CESSATION 375 0.0073
814 BEDRIDDEN 96 0.0073
815 CANDIDA INFECTION 123 0.0073
816 FEMUR FRACTURE 225 0.0073
817 RASH GENERALISED 186 0.0072
818 HYPOKINESIA 104 0.0072
819 DYSPNOEA 3999 0.0071
820 NIGHTMARE 244 0.0070
821 HYPOTHYROIDISM 225 0.0070
822 EYE SWELLING 260 0.0070
823 OXYGEN SATURATION DECREASED 392 0.0070
824 MENSTRUATION IRREGULAR 185 0.0069
825 MEDICATION ERROR 382 0.0069
826 AMENORRHOEA 120 0.0068
827 HEPATITIS 175 0.0068
828 BLOOD SODIUM DECREASED 128 0.0068
829 SEPTIC SHOCK 294 0.0067
830 HUNGER 94 0.0067
831 HYPERHIDROSIS 869 0.0067
832 PHARYNGEAL OEDEMA 102 0.0066
833 DYSKINESIA 269 0.0066
834 PERITONITIS 137 0.0066
835 RENAL DISORDER 307 0.0066
836 MENORRHAGIA 129 0.0066
837 DRY MOUTH 531 0.0065
838 PRODUCT DOSE OMISSION 426 0.0065
839 PSYCHOMOTOR HYPERACTIVITY 108 0.0065
840 PSYCHOTIC DISORDER 192 0.0065
841 ERYTHEMA 1335 0.0065
842 DYSGEUSIA 482 0.0065
843 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 111 0.0065
844 TACHYCARDIA 569 0.0064
845 OSTEOPENIA 97 0.0064
846 SKIN DISCOLOURATION 291 0.0063
847 MOOD ALTERED 172 0.0063
848 ACUTE RESPIRATORY FAILURE 121 0.0063
849 OSTEONECROSIS 206 0.0063
850 MIDDLE INSOMNIA 117 0.0063
851 PARANOIA 108 0.0063
852 PREMATURE BABY 188 0.0062
853 THERAPEUTIC RESPONSE DECREASED 377 0.0062
854 ACCIDENTAL OVERDOSE 227 0.0062
855 CARDIAC DISORDER 580 0.0062
856 TOOTH LOSS 128 0.0062
857 ACNE 463 0.0061
858 RED BLOOD CELL COUNT DECREASED 172 0.0060
859 RETCHING 128 0.0060
860 THIRST 105 0.0059
861 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130 0.0059
862 HYPOTENSION 1172 0.0058
863 DEVICE DEFECTIVE 100 0.0058
864 PRESYNCOPE 140 0.0058
865 ORAL PAIN 128 0.0057
866 MENINGIOMA 89 0.0057
867 PSORIASIS 743 0.0057
868 PAIN IN JAW 161 0.0057
869 NEUROPATHY PERIPHERAL 540 0.0057
870 DERMATITIS 118 0.0056
871 FEELING JITTERY 107 0.0056
872 ALANINE AMINOTRANSFERASE INCREASED 342 0.0056
873 RASH ERYTHEMATOUS 266 0.0056
874 SUICIDAL IDEATION 507 0.0055
875 BLOOD PRESSURE SYSTOLIC INCREASED 107 0.0055
876 JAUNDICE 147 0.0055
877 BLOOD BILIRUBIN INCREASED 147 0.0054
878 BONE DISORDER 99 0.0054
879 ANGINA PECTORIS 152 0.0053
880 ENCEPHALOPATHY 129 0.0052
881 LIP SWELLING 174 0.0052
882 MYOCARDIAL INFARCTION 911 0.0052
883 PULMONARY OEDEMA 231 0.0052
884 PERICARDIAL EFFUSION 119 0.0051
885 DEATH 4422 0.0051
886 BLOOD ALKALINE PHOSPHATASE INCREASED 127 0.0051
887 PRODUCT PREPARATION ERROR 105 0.0051
888 HYPOKALAEMIA 234 0.0051
889 DEVICE LEAKAGE 217 0.0050
890 DIABETES MELLITUS INADEQUATE CONTROL 87 0.0049
891 COMA 230 0.0048
892 RESPIRATORY FAILURE 352 0.0048
893 ATRIAL FIBRILLATION 465 0.0048
894 ARRHYTHMIA 226 0.0048
895 HAEMATOMA 123 0.0047
896 PELVIC PAIN 86 0.0047
897 HEPATIC FAILURE 142 0.0047
898 UNRESPONSIVE TO STIMULI 121 0.0047
899 PRODUCT STORAGE ERROR 409 0.0047
900 ASPARTATE AMINOTRANSFERASE INCREASED 248 0.0047
901 HAEMATEMESIS 118 0.0047
902 DYSPNOEA EXERTIONAL 175 0.0046
903 CEREBRAL HAEMORRHAGE 166 0.0046
904 MULTIPLE ORGAN DYSFUNCTION SYNDROME 129 0.0045
905 EMOTIONAL DISTRESS 546 0.0045
906 DRY EYE 225 0.0045
907 LACRIMATION INCREASED 133 0.0044
908 DEVICE MALFUNCTION 309 0.0044
909 WHITE BLOOD CELL COUNT DECREASED 476 0.0044
910 MOVEMENT DISORDER 139 0.0043
911 MELAENA 95 0.0043
912 OCULAR HYPERAEMIA 202 0.0043
913 INJECTION SITE REACTION 290 0.0042
914 AGEUSIA 105 0.0042
915 PNEUMONITIS 113 0.0041
916 PAIN OF SKIN 111 0.0041
917 PRODUCT USE ISSUE 774 0.0041
918 EYE PRURITUS 138 0.0041
919 PLEURAL EFFUSION 248 0.0041
920 EXPOSURE DURING PREGNANCY 251 0.0040
921 PROSTATE CANCER 324 0.0040
922 RESPIRATORY ARREST 111 0.0040
923 SUICIDE ATTEMPT 243 0.0040
924 ABNORMAL BEHAVIOUR 158 0.0040
925 ASCITES 116 0.0039
926 RENAL FAILURE 521 0.0039
927 ACUTE MYOCARDIAL INFARCTION 115 0.0039
928 CARDIAC ARREST 314 0.0038
929 CORONARY ARTERY DISEASE 115 0.0038
930 PANCREATIC CARCINOMA 109 0.0038
931 RESTLESSNESS 137 0.0037
932 VAGINAL HAEMORRHAGE 161 0.0037
933 BRADYCARDIA 196 0.0037
934 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 202 0.0037
935 ANGIOEDEMA 161 0.0036
936 AGITATION 267 0.0036
937 UNDERDOSE 260 0.0036
938 INTERSTITIAL LUNG DISEASE 172 0.0035
939 DEPRESSED LEVEL OF CONSCIOUSNESS 140 0.0035
940 HALLUCINATION 264 0.0035
941 BLOOD GLUCOSE DECREASED 166 0.0035
942 CARDIAC FAILURE CONGESTIVE 277 0.0034
943 GASTROINTESTINAL HAEMORRHAGE 282 0.0034
944 CARDIOVASCULAR DISORDER 85 0.0033
945 THERAPEUTIC RESPONSE UNEXPECTED 147 0.0033
946 RENAL IMPAIRMENT 274 0.0033
947 CARDIAC FAILURE 257 0.0032
948 INCORRECT DOSE ADMINISTERED 723 0.0032
949 EPISTAXIS 232 0.0031
950 INJECTION SITE RASH 95 0.0031
951 PRODUCT USE IN UNAPPROVED INDICATION 762 0.0031
952 INJECTION SITE PRURITUS 204 0.0030
953 DRY SKIN 391 0.0029
954 DRUG EFFECT INCOMPLETE 105 0.0029
955 THROMBOCYTOPENIA 323 0.0029
956 HAEMATURIA 97 0.0028
957 RENAL FAILURE ACUTE 120 0.0028
958 INJECTION SITE SWELLING 209 0.0027
959 AGGRESSION 133 0.0027
960 INJECTION SITE PAIN 813 0.0026
961 COMPLETED SUICIDE 220 0.0026
962 BLADDER CANCER 155 0.0026
963 BLOOD GLUCOSE INCREASED 489 0.0026
964 PLATELET COUNT DECREASED 270 0.0025
965 EYE IRRITATION 145 0.0025
966 INJECTION SITE MASS 92 0.0025
967 INJECTION SITE BRUISING 196 0.0025
968 UNEVALUABLE EVENT 184 0.0024
969 HYPOGLYCAEMIA 117 0.0024
970 DISEASE RECURRENCE 113 0.0024
971 RENAL CANCER 113 0.0024
972 ACUTE KIDNEY INJURY 358 0.0023
973 INJECTION SITE ERYTHEMA 286 0.0023
974 BLOOD CREATININE INCREASED 149 0.0023
975 SKIN IRRITATION 100 0.0022
976 LEUKOPENIA 107 0.0021
977 SKIN EXFOLIATION 162 0.0019
978 PANCYTOPENIA 107 0.0019
979 DEVICE ISSUE 168 0.0019
980 DISEASE PROGRESSION 221 0.0019
981 HYPONATRAEMIA 95 0.0017
982 SKIN BURNING SENSATION 116 0.0016
983 CHRONIC KIDNEY DISEASE 116 0.0015
984 INJECTION SITE HAEMORRHAGE 121 0.0015
985 DRUG WITHDRAWAL SYNDROME 118 0.0013
986 OVERDOSE 278 0.0013
987 DRUG INTERACTION 200 0.0013
988 NEUTROPENIA 155 0.0011
989 INTENTIONAL PRODUCT MISUSE 87 0.0010
990 DRUG DEPENDENCE 146 0.0009
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 151 0.0007